InvestorsHub Logo
Post# of 253152
Next 10
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: Bickema post# 217579

Thursday, 03/01/2018 11:11:38 AM

Thursday, March 01, 2018 11:11:38 AM

Post# of 253152

RVNC/MYL—So what are your potential reservations about the deal?

My reservation is that RVNC isn't getting enough early (i.e. up-front + clinical-milestones) cash for a deal of this nature.

As things stand (following the MYL deal), RVNC might be able to get to the US launch of RT002 without raising additional capital, but they would be cutting it close.

p.s. I don't think MYL could have developed a Botox biosimilar on its own.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.